News
AFTER years of fad diets and sweat-soaked gym sessions, ex-Gogglebox favourite Amy Tapper has undergone a major body ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
17h
Irish Star on MSNWeight-loss drugs linked to devastating eye condition, new research confirms
Research carried out over the past year has shown a link between using GLP-1 medication for weight loss and a dangerous eye condition that results in sudden vision loss ...
Hair loss could be about to have its Ozempic moment after a study suggested that researchers had found a new drug that could ...
21h
Zacks Investment Research on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...
Ozempic users who suffer strokes appear to have much lower death rates and better long-term survival. Evidence points to a ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
WEIGHT loss jabs are weaving themselves into the fabric of our daily lives and chances are you know someone taking them – or ...
Ozempic a brand name for semaglutide works by mimicking a natural hormone that helps your body regulate blood sugar reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results